σ1 Receptor ligand 1

Compound 5I is a potent and selective σ1 receptor ligand (Ki = 3.9 nM) with high plasma protein binding and metabolic stability. This profile supports its utility in neuroscience research, such as for neuropathic pain models, and in cancer studies exploring σ1 receptor modulation in vitro and in vivo.